Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
ImageWare Systems, Inc. (ImageWare) (OTCQB: IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, today introduced GoVerifyID® Enterprise Suite, an innovative, multi-modal, multi-factor biometric authentication solution for the enterprise market. An algorithm-agnostic solution, GoVerifyID Enterprise Suite is the first ever end-to-end biometric platform that seamlessly integrates with an enterprise’s existing Microsoft infrastructure, offering businesses a turnkey biometric solution for quick deployment in an afternoon or less.
“Last year nearly 80 percent of businesses reported a data breach. As the digital workforce expands, with data extended to external stakeholders and across numerous types of devices and systems, the need for high-assurance, enterprise-wide protection has intensified,” said Jim Miller, chairman & CEO of ImageWare. “The traditional security perimeters have changed and executives are being held accountable for safeguarding data against potentially devastating breaches that can tarnish a brand’s reputation. Armed with GoVerifyID Enterprise Suite, corporations have access to a scalable and affordable solution that works with their existing Microsoft infrastructure and gives them the ultimate peace of mind.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7978451-imageware-goverifyid-enterprise-suite/
See America, Allergan’s initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to “stand in the way of darkness”.
The video harnesses Common’s striking spoken word ability, calling on Americans to fight against vision loss and prioritize their vision. Common highlights the 61 million Americans at-risk of severe vision loss, and challenges us all to imagine a life without sight.
“I'm proud to join Allergan in the fight against preventable blindness,” said Common. “Sight is something that far too many of us take for granted. I hope our message resonates with people across the country, no matter what age or background.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Today, on the International Day for the Abolition of Slavery, the Global Freedom Network (GFN) has brought together leaders of the Christian Catholic, Anglican and Orthodox, as well as Buddhist, Hindu, Jewish and Muslim faiths who have jointly declared one common humanitarian endeavour: To eradicate modern slavery by 2020 throughout our world and for all time as a crime against humanity.
A number of faith leaders spoke at the event and video messages were given by His All-Holiness Ecumenical Patriarch Bartholomew and by Grand Ayatollah Sheikh Basheer Hussain al Najafi who could not attend the ceremony but are equally committed to eradicating modern slavery and human trafficking.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7391151-faith-leaders-eradicate-slavery/
As more than 2 million freshman head off to college, they enter one of the most dangerous times for harmful and underage student drinking—the first six weeks of their first year. And while there are numerous options available to address student drinking -- they are not all equally effective.
WHAT: The NIH’s National Institute on Alcohol Abuse and Alcoholism will hold a press briefing to announce the CollegeAIM (Alcohol Intervention Matrix) guide and website – the centerpiece of which is a new comprehensive and easy-to-use tool that will help inform decisions about alcohol interventions and guide college staff to science-based strategies.
Developed with input from leading alcohol researchers and college staff, CollegeAIM is distinctive because of the number and expertise of its contributors, the breadth of research covered by its analysis, and its user-friendly format.
To view the multimedia release go to:
http://www.multivu.com/players/English/7587851-niaaa-collegeaim-alcohol-intervention/
Northwestern Mutual, presenting sponsor of the 2016 Rose Bowl Game®, today unveiled its float design for the 127th Rose Parade® presented by Honda. Titled Dancing into Adventure, it will draw attention to the fight against childhood cancer by showcasing the greatest adventure and dream of Peyton Richardson, a 13-year-old aspiring ballerina from Sugar Land, Texas, who is battling leukemia.
The theme of this year’s parade is Find Your Adventure. As an aspiring ballerina, Peyton wants to travel the world to see performances from the world’s most distinguished ballet companies and have a dance lesson with their principal dancers. Northwestern Mutual is using its sponsorship to bring Peyton’s adventure to life in flowers and raise awareness about childhood cancer.
“Peyton’s unique, positive way of using ballet to battle cancer and stay focused on her dream is truly amazing,” said Conrad York, vice president of marketing at Northwestern Mutual. “At Northwestern Mutual, we know that each family has a dream in mind for their future, and we are here to support them every step of the way.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7422155-northwestern-mutual-rose-parade-float/
The St. Jude Promesa y Esperanza® (Promise and Hope), an initiative by St. Jude Children’s Research Hospital® and Univision Radio, the leading radio network serving Hispanic America, partner to increase awareness for national fundraiser against childhood cancer. As part of this partnership, Univision Radio will broadcast special programming on February 10 and 11 asking listeners to become Angeles de Esperanza (Angels of Hope) by making a donation of $20 per month, to find cures and save children.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65476-univision-radio-st-jude-children-s-research-hospital-national-fundraiser
Handheld Group, a leading manufacturer of rugged mobile computers, today announced the launch of its new Android tablet, the ALGIZ RT7. The ALGIZ RT7 is a powerful, lightweight and ergonomic 7-inch tablet designed for reliable performance in demanding environments.
The Algiz RT7, which runs Android 5.1.1 (Lollipop), provides a wide range of features and exceptional value to mobile workforces. It’s fully rugged, meeting stringent MIL-STD-810G U.S. military standards for protection against drops, vibrations and extreme temperatures, and its IP65 rating means that it’s waterproof as well as fully sealed against sand and dust. Weighing just 650 grams, the Algiz RT7 is designed for mobility.
Industry-leading technology from Qualcomm — an MSM8916 (Snapdragon) chipset and 1.2 GHz quad-core processor — powers the Algiz RT7 for impressive processing speed, ultra-fast connectivity and long battery life. The Algiz RT7 comes standard with LTE data and voice capabilities as well as 802.11 b/g/n WLAN, BT Class 1 and Class 2, and NFC functionality. It also boasts dual cameras (8-megapixel rear-facing and 2-megapixel front-facing), as well as dual SIM card slots. The unit comes with a built-in accelerometer, gyroscope and e-compass and a stand-alone u-blox GPS receiver for navigation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7688851-handheld-ultra-rugged-android-tablet/
House of Napius is India's first line of radiation safe maternity wear using path breaking NESA technology (Non-Ionizing Electromagnetic Shielding Alternatives.
Most expectant mothers understand that carrying a child means taking extra safety measures to protect the growing life. Mothers-to-be are aware that they need to avoid certain chemicals, foods, and some beverages. Our line of radiation safe maternity wear provides an additional safeguard by shielding against radiation from cell phones, wireless routers, laptop and computers. House of Napius offers a wide range of revolutionary, radiation safe Maternity wear for the first time in India.
With a lack of choice and growing radiation concerns Founder Director, Nehal Mehta says: “Today we cannot live a gadget or appliance free lifestyle. At House of Napius, we have created a solution to block the radiation from these gadgets which are used on a daily basis such as cellphones, microwaves, laptops, scanners and ipads. We are launching our first product category of maternity wear and will be expanding into other categories such a kidswear, womenswear and menswear in the future.”
When it comes to dressing during pregnancy, comfort and style are key factors/aspects. The new range of maternity wear by House of Napius includes office wear, day wear, resort, night wear and cocktail dresses. Each garment is designed to not only protect the child, but provide unparalleled comfort and ease of use for the pregnant mother. House of Napius maternity wear is available in a multitude of colours’ and patterns and will keep your child protected all through those precious nine months.
To view the Multimedia release go to:
http://www.multivu.com/players/English/7595451-house-napius-maternity-wear-india/
Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
The NFC-empowered Momento Pearl™ from Galatea: Jewelry by Artist is the first cultured pearl to contain near field communication technology, allowing a user to create a tailored voice message that can be played when the pearl is tapped against a compatible mobile device. Taking smart jewelry to a completely new, emotional level, the patent-pending Momento Pearl (U.S. Patent No. 14/517.827 and Trademark 86/434,536) can also store a variety of digital content including images, messages and videos.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7396251-galatea-jewelry-by-artist-nfc-empowered-momento-pearl/
